On July 01, 2024, Fischer Medical Ventures Limited (formerly Fischer Chemic Limited) is excited to announce a successful partnership with Nervotec Pte Ltd, a Singapore-based innovator. Together, they aim to enable blood pressure, haemoglobin, and HbA1C screening using camera-enabled devices. This collaboration represents a significant step in healthcare screening, using advanced, contactless video-based technology to …